Khabre branded placeholder image

science

Study Maps Differences in ctDNA Release in Breast Cancer

A bioRxiv preprint reports that tumour-cell states, mutations, tumour architecture and immune signals were associated with differences in ctDNA release in ten patients with non-metastatic HR+/HER2− breast cancer. The findings offer a biological framework for understanding why tumour DNA detected in tissue may differ from what appears in blood.

Khabre branded placeholder image

health

Plasma Neoepitope Search Hit Limits in a Four-Patient Study

A bioRxiv preprint reports that plasma mass spectrometry could detect some tumor-associated peptides, but neoepitope searches were constrained by limited overlap between cfDNA and tumor mutations and by MS sensitivity. Tissue remained the stronger reference for identifying tumor mutations and neoepitopes.